PR104 in Treating Patients With Previously Untreated or Relapsed Small Cell Lung Cancer
Public ClinicalTrials.gov record NCT00544674. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Multi-Center, Open-Label, Trial of PR104 in Treatment Naive and Sensitive-relapse Small Cell Lung Cancer
Study identification
- NCT ID
- NCT00544674
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Proacta, Incorporated
- Industry
- Enrollment
- 5 participants
Conditions and interventions
Conditions
Interventions
- PR104 Drug
- F-18-fluoromisonidazole Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2007
- Primary completion
- Jun 30, 2008
- Completion
- Dec 31, 2008
- Last update posted
- Dec 9, 2012
2007 – 2009
United States locations
- U.S. sites
- 18
- U.S. states
- 11
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Clinical Research Center, Incorporated | Tucson | Arizona | 85715 | — |
| Tower Cancer Research Foundation | Beverly Hills | California | 90211 | — |
| California Cancer Care, Incorporated - Greenbrae | Greenbrae | California | 94904-2007 | — |
| Pacific Shores Medical Group - Long Beach | Long Beach | California | 90813 | — |
| Stanford Cancer Center | Stanford | California | 94305-5824 | — |
| Front Range Cancer Specialists | Fort Collins | Colorado | 80524-4038 | — |
| University of Florida Health Science Center - Jacksonville | Jacksonville | Florida | 32209 | — |
| Joliet Oncology-Hematology Associates, Limited - West | Joliet | Illinois | 60435 | — |
| Welborn Clinic | Evansville | Indiana | 47713 | — |
| James Graham Brown Cancer Center at University of Louisville | Louisville | Kentucky | 40202 | — |
| Kentuckiana Cancer Institute, PLLC | Louisville | Kentucky | 40202 | — |
| Purchase Cancer Group - Paducah | Paducah | Kentucky | 42001 | — |
| Barbara Ann Karmanos Cancer Institute | Detroit | Michigan | 48201-1379 | — |
| Cancer and Blood Specialists of Nevada - Henderson | Henderson | Nevada | 89074 | — |
| Gabrail Cancer Center - Canton Office | Canton | Ohio | 44718 | — |
| Charles M. Barrett Cancer Center at University Hospital | Cincinnati | Ohio | 45219 | — |
| Good Samaritan Hospital Cancer Treatment Center | Cincinnati | Ohio | 45220 | — |
| Peninsula Cancer Institute - Newport News Office | Newport News | Virginia | 23601 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00544674, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 9, 2012 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00544674 live on ClinicalTrials.gov.